Medicinal Oxygen Liquid

Oxygen, the active ingredient in Medicinal Oxygen Liquid, is a medical gas presented as a liquid for nasal use. It supplies supplemental oxygen to increase arterial oxygen tension and improve tissue oxygenation in patients with hypoxemia, respiratory distress, or acute and chronic lung disease.

GNH USA supplies Medicinal Oxygen Liquid as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Medicinal Oxygen Liquid is used in oxygen therapy to address conditions where tissue oxygenation is compromised.

- Hypoxemia: raises arterial oxygen levels and supports cellular metabolism. - Respiratory distress: alleviates shortness of breath by providing additional oxygen. - Acute or chronic lung disease requiring supplemental oxygen: improves gas exchange and reduces work of breathing.

Oxygen therapy may be associated with both frequent and infrequent adverse reactions.

Common Side Effects: - Nasal dryness or irritation - Mild headache - Cough or throat discomfort - Fatigue or drowsiness - Nausea - Mild dizziness

Serious or Rare Side Effects: - Pulmonary oxygen toxicity (e.g., cough, chest pain) - Central nervous system toxicity, including seizures - Fire hazard due to high oxygen concentration - Retinopathy of prematurity in neonates - Hypercapnia in patients with COPD - Barotrauma from high‑pressure delivery systems

When using Medicinal Oxygen Liquid, consider the following safety measures.

- Patient assessment: evaluate oxygen saturation and underlying respiratory conditions before initiation. - Monitoring: continuously monitor SpO2 and watch for signs of hyperoxia. - Fire safety: keep away from open flames, sparks, and smoking materials. - Equipment check: ensure delivery devices are compatible and free of leaks. - Special populations: use caution in patients with COPD or those receiving sedatives. - Store at ambient temperature: keep the container in its original packaging, protect from heat and direct sunlight.

Oxygen can interact with certain therapies, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid): - Nitric oxide therapy: increased risk of methemoglobinemia. - Hyperbaric oxygen treatment: heightened potential for oxygen toxicity. - Certain chemotherapeutic agents (e.g., bleomycin): may exacerbate pulmonary toxicity.

Moderate Interactions (Monitor Closely): - Bronchodilators: may increase oxygen demand, requiring dose adjustment. - Sedatives or opioids: enhanced risk of respiratory depression. - Diuretics: monitor fluid balance as oxygen therapy can affect renal perfusion.